We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Royal Gold
RGLD
$19.8B
| $1.24M | ﹤0.01% |
+14,400
| New | +$1.21M |
|
|
ABB
827
DELISTED
ABB Ltd
ABB
| $1.23M | ﹤0.01% |
+52,000
| New | +$1.34M |
|
828
Shopify
SHOP
$200B
| $1.23M | ﹤0.01% |
99,000
-3,819,740
| -97% | -$49.4M |
|
829
Zoetis
ZTS
$30.9B
| $1.23M | ﹤0.01% |
14,700
-525,347
| -97% | -$41.4M |
|
830
Movado Group
MOV
$817M
| $1.22M | ﹤0.01% |
31,795
-1,500
| -5% | -$47.9K |
|
831
NACCO Industries
NC
$312M
| $1.22M | ﹤0.01% |
37,163
+1,905
| +5% | +$76.7K |
|
832
Vodafone
VOD
$36.4B
| $1.22M | ﹤0.01% |
+43,900
| New | +$1.31M |
|
|
DQ
833
Daqo New Energy
DQ
$989M
| $1.22M | ﹤0.01% |
124,600
-4,085
| -3% | -$44.2K |
|
|
ARRY
834
DELISTED
Array Biopharma Inc
ARRY
| $1.21M | ﹤0.01% |
+74,219
| New | +$1.19M |
|
835
Cisco
CSCO
$483B
| $1.2M | ﹤0.01% |
+27,977
| New | +$1.19M |
|
836
Gogo Inc
GOGO
$432M
| $1.19M | ﹤0.01% |
137,639
+82,850
| +151% | +$799K |
|
|
GTS
837
DELISTED
Triple-S Management Corporation
GTS
| $1.19M | ﹤0.01% |
+47,774
| New | +$1.14M |
|
838
J. Jill
JILL
$279M
| $1.19M | ﹤0.01% |
63,986
+45,668
| +249% | +$1.46M |
|
839
Dentsply Sirona
XRAY
$2.34B
| $1.19M | ﹤0.01% |
+23,600
| New | +$1.39M |
|
|
CORR
840
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $1.17M | ﹤0.01% |
+31,188
| New | +$1.16M |
|
841
Ambev
ABEV
$45.4B
| $1.17M | ﹤0.01% |
+160,500
| New | +$1.1M |
|
|
BKCC
842
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $1.16M | ﹤0.01% |
191,729
+529
| +0.3% | +$3.11K |
|
843
KB Home
KBH
$3.47B
| $1.14M | ﹤0.01% |
39,920
-193,404
| -83% | -$6.02M |
|
|
PNNT
844
Pennant Park Investment Corp
PNNT
$242M
| $1.13M | ﹤0.01% |
169,400
-296,580
| -64% | -$2.06M |
|
845
Star Group
SGU
$416M
| $1.13M | ﹤0.01% |
+121,100
| New | +$1.2M |
|
846
Lazard
LAZ
$4.16B
| $1.13M | ﹤0.01% |
21,468
-237,119
| -92% | -$13.2M |
|
847
Ribbon Communications
RBBN
$367M
| $1.13M | ﹤0.01% |
221,148
+94,502
| +75% | +$611K |
|
848
United Airlines
UAL
$40.2B
| $1.13M | ﹤0.01% |
+16,200
| New | +$1.12M |
|
|
TRTX
849
TPG RE Finance Trust
TRTX
$608M
| $1.12M | ﹤0.01% |
+56,165
| New | +$1.07M |
|
|
ZIXI
850
DELISTED
Zix Corporation
ZIXI
| $1.12M | ﹤0.01% |
261,604
-236,935
| -48% | -$1.02M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.